Epiterna
EPITERNA develops affordable products that can safely slow the ageing process to prevent age-related disease, delay functional decline, and extend life.
Epalinges, Switzerlandwww.epiterna.com ↗
Total raised
€10M
€10,000,000
Funding rounds
1
Investors
1
distinct backers
Active since
2023-08
latest 2023-08
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood22
base rate 30% for Other
- ▼ Overdue vs cohort gap
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-08-01 | Other | €10M | Prima Materia | View deal → |
Investors
1Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Climeworks€920MSwitzerland · Cleantech
- Energy Vault€896MSwitzerland · Energy